. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J Nutr Health Aging. 2002;6(5):324-31. PubMed.


Please login to recommend the paper.


  1. Interesting speculation but the proof will be in the pudding. Ultimately, we don't yet know what happens when statins are given to normal cholesterolemic individuals.

Make a Comment

To make a comment you must login or register.